Alzamend Neuro, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alzamend Neuro, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2020 to Q2 2024.
  • Alzamend Neuro, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2024 was $1.96M.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.65M.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $200.000.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $18.9M, a 324% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.96M May 1, 2024 Jul 31, 2024 10-Q 2024-09-11
Q2 2021 $14.9M +$14.8M +19263% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q2 2020 $77K May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.